Cytokinetics Inc. buy B. Riley
Start price
21.01.26
/
50%
€55.00
Target price
21.01.27
-
Performance (%)
21.60%
Price
22:25
€66.88
Summary
This prediction is currently active. The prediction currently has a performance of 21.60%. This prediction currently runs until 21.01.27. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -3.165% | -3.165% |
| iShares Core DAX® | 3.901% | 2.667% |
| iShares Nasdaq 100 | -2.603% | -7.934% |
| iShares Nikkei 225® | -0.545% | -9.754% |
| iShares S&P 500 | -0.881% | -1.488% |
Comments by B__Riley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by B__Riley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.60
04.06.24
04.06.24
€84.53
04.06.25
04.06.25
-35.43%
05.06.25
05.06.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.40
07.11.23
07.11.23
€61.81
07.11.24
07.11.24
61.68%
08.11.24
08.11.24